Juvederm Voluma is a hyaluronic acid dermal filler developed by Allergan using Vycross crosslinking technology. It is FDA-approved for cheek augmentation and the correction of age-related mid-face volume loss in adults over 21, and is one of the longest-lasting HA fillers available with clinical studies supporting duration of up to two years. For aesthetic practitioners, understanding its formulation, indications, technique considerations, and patient management is essential for consistent, natural-looking results.
This guide covers everything practitioners need to know about Juvederm Voluma — from product specifications and clinical applications to patient selection, injection technique, and post-treatment care. Health Supplies Plus supplies authentic Juvederm Voluma to licensed medical professionals at wholesale pricing.
Procuring Juvederm Voluma for Your Practice
Juvederm Voluma is available exclusively to licensed medical professionals. Health Supplies Plus supplies authentic product through verified supply channels with full traceability and cold-chain integrity. Register your practice for free to complete one-time license verification — most accounts are approved within 1 to 2 hours. Once verified, you can browse and order across the full Juvederm range at competitive wholesale pricing with tiered volume savings.
Regulatory requirements for purchasing and administering dermal fillers vary by jurisdiction. Familiarize yourself with local regulations, scope of practice requirements, and any certification or supervision requirements before offering injectable treatments in your practice.
Juvederm Voluma: Product Specifications
Each syringe of Juvederm Voluma contains 1.0 mL of Vycross-crosslinked hyaluronic acid at 20 mg/mL, plus 0.3% lidocaine hydrochloride. The Vycross formulation blends low and high molecular weight HA chains in a tightly crosslinked matrix, producing a high G’ (elastic modulus) cohesive gel with significant lifting capacity. This is what differentiates Voluma from earlier-generation Hylacross products like Juvederm Ultra — the Vycross crosslinking produces a longer-lasting, more structurally supportive gel with less water uptake and typically less post-injection swelling.
The volume required per treatment varies by patient. Factors include baseline facial anatomy, degree of mid-face volume loss, injection plane, and aesthetic goals. A detailed pre-treatment assessment is essential for determining appropriate dosing. Starting conservatively and reviewing at two weeks before adding volume is the safest approach.
Longevity of Juvederm Voluma Results
Clinical studies supporting FDA approval demonstrated duration of effect of up to two years for cheek augmentation — among the longest documented for any HA filler. Individual duration varies based on patient metabolism, treatment area, injection volume, and technique. Most patients begin to notice gradual volume reduction between 12 and 18 months. A touch-up treatment at that point maintains optimal correction without requiring a full repeat course.
Determining the Appropriate Dosage
One syringe (1.0 mL) may be sufficient for subtle enhancement, minor asymmetry correction, or small area touch-ups. Moderate to significant mid-face volume loss typically requires two or more syringes for balanced, natural-looking results. Voluma’s high G’ and lifting capacity mean a relatively small volume produces significant structural change — this is both an advantage and a reason to start conservatively.
Overfilling creates an unnatural result and is more difficult to correct than underfilling. A staged approach — treating conservatively and assessing at two weeks — is preferable to attempting to reach the final result in a single session.
Juvederm Voluma vs. Other Fillers for Mid-Face and Cheek Augmentation
When selecting a filler for mid-face and cheek indications, the key differentiators are mechanism of action, injection depth, G’, and duration. The table below provides a clinical comparison of commonly used products:
- Juvederm Voluma — Vycross HA, high G’, supraperiosteal placement, FDA-approved for cheek augmentation, up to two years duration. Reversible with hyaluronidase.
- Restylane Lyft — NASHA HA, larger particle size, deep dermal to supraperiosteal placement, FDA-approved for cheek augmentation, 12 to 18 months duration. Reversible with hyaluronidase.
- Radiesse — Calcium hydroxylapatite, immediate volume plus collagen stimulation, subdermal to supraperiosteal placement, 12 to 18+ months. Not reversible with hyaluronidase.
- Sculptra — Poly-L-lactic acid biostimulator, gradual collagen induction over multiple sessions, results develop over months and can last two or more years. Not reversible.
- Juvederm Volift — Vycross HA, mid-range G’, mid-to-deep dermal placement, suited to nasolabial folds and mid-face contouring, 15 to 18 months duration. Reversible with hyaluronidase.
For practitioners considering HA-based cheek augmentation specifically, the choice between Voluma and Restylane Lyft often comes down to gel behavior preference and practitioner familiarity — both are FDA-approved for the indication with comparable safety profiles.
Juvederm Voluma: Clinical Overview
Indications and Patient Selection
Juvederm Voluma is indicated for cheek augmentation and correction of age-related mid-face volume loss in adults over 21. Suitable candidates typically present with mid-face deflation, flattening of the malar eminence, or descent of the malar fat pad. A thorough pre-treatment assessment of facial anatomy, skin quality, prior filler history, and aesthetic goals is essential before proceeding.
Contraindications include known hypersensitivity to hyaluronic acid or any product component, active infection or inflammation at the intended injection site, and pregnancy or breastfeeding. Patients with a history of severe allergic reactions or anaphylaxis and those on anticoagulant therapy require additional screening and clinical judgment before treatment.
Injection Technique
Juvederm Voluma is designed for deep injection — supraperiosteal or deep subcutaneous placement in the cheek and mid-face. Shallow placement of a high-G’ product like Voluma risks palpability, surface irregularity, or visible product. For more superficial mid-face correction, a softer Vycross formulation such as Volift is more appropriate.
Bolus or depot injection at the supraperiosteal level is the standard technique for structural cheek support. Blunt-tip cannulas are widely used for mid-face Voluma injection, reducing vascular trauma risk in an area with several important vascular structures. Needle injection remains appropriate for precise structural placement at the periosteal level. Slow injection speed, low pressure, and small bolus volumes are essential vascular safety measures regardless of delivery method.
Current guidance from major aesthetic medicine societies does not support mandatory aspiration as a reliable standalone safety step. Primary vascular safety relies on anatomical knowledge, technique, and injection parameters. Practitioners must be trained in vascular occlusion recognition and management, and have hyaluronidase immediately available at every session. Voluma is reversible with hyaluronidase — an important safety and flexibility advantage over non-HA structural fillers.
Key Clinical Benefits
- FDA-approved for cheek augmentation in adults over 21
- Up to two years duration — the longest clinically demonstrated for HA fillers in this indication
- Vycross technology produces less post-injection swelling than earlier Hylacross formulations
- Contains lidocaine for improved patient comfort during injection
- Reversible with hyaluronidase
- Immediate, natural-looking volumization with strong lift capacity
Pre-Treatment Protocol
Advise patients on the following before their Voluma appointment:
- Avoid aspirin, NSAIDs, fish oil, vitamin E, and alcohol for at least one week prior to treatment where clinically appropriate — these increase bruising risk
- Stay well hydrated in the days before treatment
- Avoid strenuous exercise and excessive heat for 24 hours before treatment
- Plan for mild swelling or bruising that may be visible for several days post-treatment — avoid major social events in the 48 hours following the appointment
Post-Treatment Care
Provide clear aftercare instructions at the end of every session:
- Cold compresses — apply for 10 to 15 minutes per hour for the first 24 hours to reduce swelling and bruising
- Avoid pressure — do not massage or press on treated areas for at least 24 hours; avoid sleeping face down for the first few nights
- Activity restrictions — avoid strenuous exercise and excessive heat for 24 hours
- Sun protection — daily broad-spectrum SPF; UV exposure accelerates HA degradation
- Pain management — acetaminophen is appropriate for mild discomfort; advise patients to avoid NSAIDs which increase bruising risk
- Follow-up — schedule a two-week review to assess final results once swelling has resolved and plan any touch-up if needed
The Juvederm Range: Product Overview
Juvederm Voluma sits within a comprehensive range of Vycross and Hylacross-formulated products. Understanding where each product fits allows practitioners to build matched treatment plans across the full face:
- Juvederm Ultra / Ultra Plus — Hylacross technology, mid-to-deep dermal placement, moderate wrinkle correction and lip augmentation, 9 to 12 months duration
- Juvederm Vollure — Vycross, mid-range G’, nasolabial fold correction, up to 18 months
- Juvederm Volbella — Vycross, low G’, lip enhancement and perioral lines, up to 12 months
- Juvederm Volift — Vycross, mid-range G’, nasolabial folds, marionette lines, mid-face contouring, 15 to 18 months
- Juvederm Voluma — Vycross, high G’, supraperiosteal cheek augmentation, up to two years
Conclusion
Juvederm Voluma remains one of the most clinically supported and widely used HA fillers for mid-face volumization. Its Vycross formulation, FDA approval, two-year duration, and reversibility with hyaluronidase make it a strong anchor product for any practice offering injectable cheek augmentation. Consistent outcomes depend on thorough patient selection, appropriate injection depth, conservative dosing, and current vascular safety practices.
Health Supplies Plus supplies authentic Juvederm Voluma to licensed medical professionals at wholesale pricing. Register your practice for free to complete one-time license verification and access our full Juvederm catalog and complete dermal fillers range.
Juvederm Voluma Frequently Asked Questions

About the Author: Doris Dickson is a specialist writer for Health Supplies Plus, focusing on the aesthetic medicine industry. She diligently researches cosmetic treatments and products to provide clear, concise information relevant to licensed medical professionals. Her work supports Health Supplies Plus’s commitment to being a reliable informational resource and trusted supplier for the aesthetic community.
Disclaimer: The content provided in this article is intended for informational purposes only and is directed towards licensed medical professionals. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, nor does it constitute an endorsement of any specific product or technique. Practitioners must rely on their own professional judgment, clinical experience, and knowledge of patient needs, and should always consult the full product prescribing information and relevant clinical guidelines before use. Health Supplies Plus does not provide medical advice.
